Loading Events
Date
Event
icon-calendar
4
Sep

Rocky Mountain Life Science Investor & Partnering Conference

Wednesday, Sep 4, 2019 —
Thursday, Sep 5, 2019
Vail Marriot Resort
715 W Lionshead Circle
Vail, CO 81657 United States

 

The Rocky Mountain Life Science Investor & Partnering Conference brings together leading investors and strategic partners from across the U.S. and the region’s top life science companies to cultivate partnerships and source investment opportunities in the areas of medical device, diagnostic, biotech, pharma and digital health.

Featuring:

  • 33 regional life science companies pitching to an audience of investor and community attendees
  • An audience of Angel Investors, Venture Firms and Strategic Partners evaluating fresh investment opportunities
  • One-on-one Partnering and Networking
  • Keynote featuring Emmanuel Fombu, Global Strategy & Digital Innovation Leader, Johnson & Johnson
  • Panel Discussion on the Emergence of Health Systems Investment in Innovation with OSF Healthcare, CU Healthcare Innovation Fund and Providence Venture

AGENDA INFORMATION

Wednesday, September 4, 2019 Arrival
5:30 – 7:30PM Opening Networking Reception
Thursday, September 5, 2019  All Day Conference & Partnering
8:00 – 9:00AM Breakfast Keynote
9:15 – 10:15AM Company presentations
10:15 – 10:45AM One on one partnering & coffee break
10:45 – 11:35AM Company presentations
11:45 – 1:15PM Lunch Keynote
1:30 – 2:40PM Company presentations
2:40 – 3:50PM One on one partnering & coffee break
4:00 – 5:30PM Closing networking Reception 

PRESENTING COMPANIES

Accure Acne
Agathos
Aktivax Inc.
AmideBio LLC
Aqualung Therapeutics
Aspero Medical
Biodesix
Brava Diagnostics
Ceria Therapeutics
ClinOne, Inc.
DiscGenics, Inc.
Epitel
Health Scholars
Health Sqyre
IMIDEX
KromaTiD, Inc 
MFB Fertility, Inc.
Microvascular Therapeutics LLC
Montana Molecular
Neuraptive Therapeutics, Inc.
OnKure
Orbit Genomics, Inc.
Photon Pharma
Securisyn Medical, LLC
Sinfonia Biotherapeutics
SiVEC Biotechnologies
Solo-Dex, Inc
Thrombo Therapeutics
Tissue Form
TriSalus Life Sciences
Validus Cellular Therapeutics
Vaporox
VitriVax

INVESTOR PANELISTS

Dennis Depenbusch, Director New Venture Initiate, BlueCross BlueShield of Kansas
Austin Duke, Venture Associate, UnityPoint Health Ventures
Steven C. Eror, Principal Investor, Hilltop Group
Travis Ferber, Partner and Head of Operations, Zero G Capital
Bryan Grulke, Partner, Capital
Kyle Lefkoff, Founder and General Partner, Boulder Ventures, Ltd.
Steven Lindseth, Senior Advisor, Triple Tree Capital
Mark Lupa, PhD, Partner, High Country Venture
Kevin McGarvey, MD, CEO and Co-Founder, Hippo Health
Timothy Mills, PhD, Managing Director, Sanderling Ventures
Janis Naeve, Managing Director, Amgen Ventures
David B. Perez, Retired President and CEO, Terumo BCT
Praful Shah, PhD, Angel Investor
Russ Yelton, President, Yolton Associates

Join us for the next conference in September 2021.